New research suggests a single dose of a vaccine for mpox is 58 per cent effective at preventing an infection. Ontario research published in the British Medical Journal (BMJ) was collected during the 2022 outbreak. Katherine Ward has this story and more in Health Matters for Sep. 12, 2024.
Health Matters
Health Matters: Single mpox vaccine 58% effective, study says
More Videos
-
Health Matters: Wegovy approved to reduce heart attack risk
-
Health Matters: Health minister to provide update on B.C. teen with bird flu
-
Health Matters: 1 in 20 Canadians not taking their meds as prescribed due to cost, study finds
-
Health Matters: ‘Suicide pod’ creator rejects claim that 1st user was strangled
-
Health Matters: New Brunswick measles outbreak rises to 44 cases
-
Carrot recall expands to Canada
You are viewing an Accelerated Mobile Webpage.
View Original Article